Advances in the Treatment of Multiple Sclerosis is a research paper published in Neurologic Clinics (2020). On theSindex it has a DataRank of 0. It has been cited 67 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 5KL2TR002547-02
Institutional Career Development Core
FWCI
4.79
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Dimethyl fumarate decreases short-term but not long-term inflammation in a focal EAE model of neuroinflammation
Additional file 1 of Dimethyl fumarate decreases short-term but not long-term inflammation in a focal EAE model of neuroinflammation
Additional file 1 of Disease-modifying therapies as positive predictors of quality of life for Sudanese patients with multiple sclerosis: a cross-sectional study
Additional file 1 of Disease-modifying therapies as positive predictors of quality of life for Sudanese patients with multiple sclerosis: a cross-sectional study